Bayview Pharmacy is pleased to present a specially compounded topical/vaginal gel formulation that combines Arginine HCl 6%, Sildenafil 2%, and Nifedipine 0.2%. This unique formulation is designed to address a range of conditions such as Vulvodynia, Lichen Sclerosus, Lichen Planus, Genital Herpes, and Dyspareunia.

Arginine HCl is an amino acid that functions to enhance blood circulation and mitigate inflammation. Sildenafil, a phosphodiesterase type 5 inhibitor, also works to improve blood flow and reduce inflammation. Nifedipine, a calcium channel blocker, aids in reducing inflammation and enhancing blood flow. The synergistic effect of these medications helps to alleviate inflammation and improve blood flow to the affected area, thereby reducing the symptoms associated with these conditions. This formulation can also help to alleviate pain and discomfort associated with these conditions.

This gel-like semisolid formulation is dispensed in a tube, specifically created for easy and controlled application in the vaginal area. It delivers medication while providing lubrication and therapeutic effects for various gynecological purposes. It is crucial to adhere to the instructions provided by your healthcare provider when using this formulation.

If you have any queries about this formulation or how it can assist in treating these conditions, please do not hesitate to contact us at Bayview Pharmacy. We are committed to helping you find the most suitable treatment option for your needs.

This compounded formulation of Arginine HCl 6%/Sildenafil 2%/Nifedipine 0.2% Topical/Vaginal Gel is a specialized treatment option for a range of gynecological conditions, including Vulvodynia, Lichen Sclerosus, Lichen Planus, Genital Herpes, and Dyspareunia. The gel is dispensed in a tube for easy and controlled application in the vaginal area, providing both medication and lubrication for therapeutic purposes.

Arginine HCl, an amino acid, works by increasing blood flow to the affected area, which can help alleviate pain and inflammation. Sildenafil, a phosphodiesterase type 5 inhibitor, aids in muscle relaxation in the area, further reducing pain and discomfort. Nifedipine, a calcium channel blocker, contributes to the reduction of inflammation and pain. The combination of these medications in this formulation can significantly reduce the symptoms associated with the aforementioned disease states.

It is crucial to note that this formulation should not be used by pregnant or breastfeeding individuals, as it may pose risks to the fetus or infant. Patients should also be aware of potential interactions with other medications they are currently taking. Therefore, it is highly recommended to discuss any potential interactions with a healthcare provider before using this formulation. This comprehensive approach ensures the safe and effective use of this compounded formulation for the treatment of various gynecological conditions.

This compounded formulation is a unique blend of Arginine HCl 6%, Sildenafil 2%, and Nifedipine 0.2% in a gel-like semisolid form. It is specifically designed for easy and controlled application in the vaginal area, providing both medication and lubrication for various gynecological purposes. The formulation is dispensed in a tube for convenience and precision.

The primary purpose of this formulation is to treat conditions such as Vulvodynia, Lichen Sclerosus, Lichen Planus, Genital Herpes, and Dyspareunia. Each component of the formulation plays a crucial role in providing relief. Arginine HCl, an amino acid, works to reduce inflammation and pain associated with these conditions. Sildenafil, a vasodilator, aids in increasing blood flow to the affected area, thereby reducing pain and discomfort. Nifedipine, a calcium channel blocker, further contributes to the reduction of inflammation and pain.

Application of this formulation should be as directed by your healthcare provider. It is crucial to adhere to the instructions and not exceed the recommended dosage. Care should be taken to avoid contact with the eyes and other sensitive areas. It is important to note that the formulation may take several weeks to show improvement in symptoms. Therefore, it is advised to continue using the formulation as directed, even if immediate results are not visible.

If you have any questions or concerns about using this formulation, it is recommended to consult with your healthcare provider. Remember, patient safety and effective treatment are our primary concerns.

This compounded formulation of Arginine HCl 6%/Sildenafil 2%/Nifedipine 0.2% Topical/Vaginal Gel is a specialized medication designed for topical and vaginal application. It has been effectively used in the treatment of various gynecological conditions such as Vulvodynia, Lichen Sclerosus, Lichen Planus, Genital Herpes, and Dyspareunia. It has also shown efficacy in addressing vaginal atrophy, vaginal dryness, and postmenopausal symptoms.

Furthermore, this formulation has been beneficial in reducing pain and inflammation associated with vulvovaginal conditions, and in enhancing sexual function. It has also been used as a preventive measure to reduce the risk of recurrent genital herpes outbreaks. However, it is important to note that this formulation is not intended to be used as a contraceptive and should not be used to treat any other condition not listed above.

Prescribers should exercise caution when recommending this formulation to patients with a history of cardiovascular disease, as it may increase the risk of adverse cardiovascular events. Patients are advised to consult with their healthcare provider for any questions or concerns regarding this medication.